J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use

Published on 23 Jan 2025 on Zacks · via Yahoo Finance

JNJ's Zacks Rank & Stocks to Consider J&J currently carries a Zacks Rank #3 (Hold). Some...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks. ...

Insider Monkey · via Yahoo Finance 23 Jan 2025

Chicago, IL – January 23, 2025 – Stocks in this week’s article are — BioMarin Pharmaceutical Inc....

Zacks · via Yahoo Finance 23 Jan 2025

JNJ's Zacks Rank & Stocks to Consider J&J currently carries a Zacks Rank #3 (Hold). Some...

Zacks · via Yahoo Finance 23 Jan 2025

Passive investing in an index fund is a good way to ensure your own returns roughly match the...

Simply Wall St. · via Yahoo Finance 21 Jan 2025

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In thi...

Insider Monkey · via Yahoo Finance 21 Jan 2025

CNC's 'Ohana Health Plan joins forces with Hope Services Hawaii to launch a residential program...

Zacks · via Yahoo Finance 15 Jan 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 14 Jan 2025

On Tuesday, Goldman Sachs reiterated its Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)...

Investing.com 14 Jan 2025

BioMarin Pharmaceutical (BMRN) San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the...

Zacks · via Yahoo Finance 10 Jan 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 9 Jan 2025